VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
2.480
-0.080 (-3.13%)
At close: Oct 20, 2025, 4:00 PM EDT
2.440
-0.040 (-1.61%)
After-hours: Oct 20, 2025, 5:40 PM EDT
VivoSim Labs Employees
As of March 31, 2025, VivoSim Labs had 13 total employees, including 5 full-time and 8 part-time employees. The number of employees decreased by 7 or -35.00% compared to the previous year.
Employees
13
Change (1Y)
-7
Growth (1Y)
-35.00%
Revenue / Employee
$10,923
Profits / Employee
-$152,846
Market Cap
6.45M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 13 | -7 | -35.00% |
| Mar 31, 2024 | 20 | -4 | -16.67% |
| Mar 31, 2023 | 24 | 6 | 33.33% |
| Mar 31, 2022 | 18 | 9 | 100.00% |
| Mar 31, 2021 | 9 | 3 | 50.00% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VIVS News
- 2 months ago - VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer - GlobeNewsWire
- 5 months ago - I Missed The Quantum Rally - I Won't Miss The Next One - Seeking Alpha
- 5 months ago - VivoSim's NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference - GlobeNewsWire
- 5 months ago - VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference - GlobeNewsWire
- 6 months ago - VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market - GlobeNewsWire
- 6 months ago - VivoSim to Carry Forward Organovo 3D Bioprinting - GlobeNewsWire
- 7 months ago - Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements - GlobeNewsWire
- 7 months ago - Organovo Provides Business Update - GlobeNewsWire